Menu
You need to sign in or sign up before continuing.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Highlight Event and Entertainment AG publishes invitation to the Annual General meeting on 25 June 2025
Highlight Event and Entertainment AG publishes invitation to the Annual General meeting on 25 June 2025
Highlight Event and Entertainment AG publishes invitation to the Annual General meeting on 25 June 2025
Fuller, Smith & Turner PLC: Transaction in own shares
Fuller, Smith & Turner PLC: Transaction in own shares
Fuller, Smith & Turner PLC: Transaction in own shares
Vistagen on Track to Deliver Topline Data From Fasedienol PALISADE-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year
Vistagen on Track to Deliver Topline Data From Fasedienol PALISADE-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year


Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product

Form 8.3 - The Vanguard Group, Inc.: Urban Logistics REIT plc
Form 8.3 - The Vanguard Group, Inc.: Urban Logistics REIT plc
Form 8.3 - The Vanguard Group, Inc.: Urban Logistics REIT plc
Form 8.3 - The Vanguard Group, Inc.: Assura plc
Form 8.3 - The Vanguard Group, Inc.: Assura plc
Form 8.3 - The Vanguard Group, Inc.: Assura plc
Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc
Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc
Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Total Voting Rights
Total Voting Rights
Total Voting Rights
Custodian Property Income REIT plc: All-share Acquisition of £22m Property Portfolio
Custodian Property Income REIT plc: All-share Acquisition of £22m Property Portfolio
Custodian Property Income REIT plc: All-share Acquisition of £22m Property Portfolio
Molten Ventures Plc: POS-Transaction in Own Shares
Molten Ventures Plc: POS-Transaction in Own Shares
Molten Ventures Plc: POS-Transaction in Own Shares
EQS-News: Daldrup & Söhne AG achieves EBIT margin of 12.7% in 2024
EQS-News: Daldrup & Söhne AG achieves EBIT margin of 12.7% in 2024
EQS-News: Daldrup & Söhne AG achieves EBIT margin of 12.7% in 2024
EQS-News: Annual Report for the 2024 financial year published
EQS-News: Annual Report for the 2024 financial year published
EQS-News: Annual Report for the 2024 financial year published
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
EQS-News: United Labels Reports on First Quarter and Expects Further Growth in Revenue and Earnings for Full-Year 2025
EQS-News: United Labels Reports on First Quarter and Expects Further Growth in Revenue and Earnings for Full-Year 2025
EQS-News: United Labels Reports on First Quarter and Expects Further Growth in Revenue and Earnings for Full-Year 2025
EQS-News: audius reports growth in total revenue in the first quarter of 2025
EQS-News: audius reports growth in total revenue in the first quarter of 2025
EQS-News: audius reports growth in total revenue in the first quarter of 2025
Lomiko Metals Announces Closing of the Second Tranche of the Hard Dollar Financing and First Tranche of Flow-Through Financing and Extension of the Flow-Through Financing
Lomiko Metals Announces Closing of the Second Tranche of the Hard Dollar Financing and First Tranche of Flow-Through Financing and Extension of the Flow-Through Financing


Lomiko Metals Inc. (TSX.V: LMR) (“Lomiko” or the “Company”) announces that it will apply to the TSX Venture Exchange (“TSXV”) for approval to close the second tranche of the hard dollar financing

Fuller, Smith & Turner PLC: Transaction in own shares
Fuller, Smith & Turner PLC: Transaction in own shares
Fuller, Smith & Turner PLC: Transaction in own shares
Form 8.3 - The Vanguard Group, Inc.: Assura plc
Form 8.3 - The Vanguard Group, Inc.: Assura plc
Form 8.3 - The Vanguard Group, Inc.: Assura plc
Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc, The
Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc, The
Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc, The
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Westwater Resources Supports U.S. Department of Commerce Decision on Chinese Graphite Anode Material
Westwater Resources Supports U.S. Department of Commerce Decision on Chinese Graphite Anode Material


Westwater Resources, Inc. (NYSE American: WWR), an energy technology and battery-grade natural graphite company (“Westwater” or the “Company”), announced today its support of the U.S. Department of

EQS-Adhoc: Deutsche Konsum REIT-AG: Deutsche Konsum REIT-AG enters into an agreement on restructuring capital increase
EQS-Adhoc: Deutsche Konsum REIT-AG: Deutsche Konsum REIT-AG enters into an agreement on restructuring capital increase
EQS-Adhoc: Deutsche Konsum REIT-AG: Deutsche Konsum REIT-AG enters into an agreement on restructuring capital increase
Fuller, Smith & Turner PLC: Transaction in own shares
Fuller, Smith & Turner PLC: Transaction in own shares
Fuller, Smith & Turner PLC: Transaction in own shares
Vistagen to Present at the Jefferies 2025 Global Life Sciences Conference New York
Vistagen to Present at the Jefferies 2025 Global Life Sciences Conference New York


Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product